CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
CapsoVision, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$6.67+0.14 (+2.14%)
Close on Oct 19, 2026
- Market cap
- $333.08M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$1.83 (+37.81%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
CapsoVision, Inc grew revenue 11.0% to $13.89M over the twelve months to Jun 30, 2026. Free cash flow was -$27.89M.
Revenue
$13.89M
+11.0% vs. a year earlier
Operating income
-$30.16M
TTM Q2 2026
Free cash flow
-$27.89M
TTM Q2 2026
EPS, diluted
-$1.03
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $333.08M
- P/E ratio
- –
- Price to sales
- 23.98
- Price to book
- 25.30
- Dividend yield
- –
- Free cash flow yield
- -8.37%
Fundamentals
- Revenue
- $13.89M
- Net income
- -$29.83M
- EPS, diluted
- -$1.03
- Free cash flow
- -$27.89M
- Book value per share
- $0.26
- Diluted shares
- 50M
Three years at a glance
Fiscal years 2023 to 2025 and trailing twelve months, USD
Revenue
$13.89M+11.0% YoY
Gross profit
$7.07M+5.6% YoY
Operating income
-$30.16M
Net income
-$29.83M
EPS, diluted
–
Free cash flow
-$27.89M
Reported periodTrailing twelve months